NIA | Technology Transfer

Methods For Enhancing Genome Stability And Telomere Elongation In Embrionic Stem Cells

Read more about Methods For Enhancing Genome Stability And Telomere Elongation In Embrionic Stem Cells

US Patent 9,012,223
Filed on 2014-04-23

THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

Read more about THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

US Patent 9,650,352
Filed on 2014-04-11

The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Japan
2014-535975
Filed on 2014-04-14

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

European Patent
12783752.4
Filed on 2012-10-15

The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

China
201280062294X
Filed on 2012-10-15

The Use Of (2S,6S)-Hydroxynorketamine, (S)-Dehydronorketamine, And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2S,6S)-Hydroxynorketamine, (S)-Dehydronorketamine, And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Canada
2851619
Filed on 2012-10-15

The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Read more about The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain

Australia
2012323845
Filed on 2012-10-15

Compositions and Methods for Delivering Inhibitory Oligonucleotides

Read more about Compositions and Methods for Delivering Inhibitory Oligonucleotides

US Patent 9,415,116
Filed on 2014-03-20

Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders

Read more about Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders

US Patent 10,471,142
Filed on 2014-03-21

Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders

Read more about Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders

South Korea
10-2014-7010605
Filed on 2014-04-21

Subscribe to NIA